- Issuer
- Innovator
- Inception Date
- Sep 13, 2018
- Region
- North America (U.S.)
- Category
- Mid Cap Growth Equities
- Leveraged
- 1x (No leverage)
- Index Tracked
- IBD Breakout Stocks Total Return Index
- Domicile
- United States
- Distribution Policy
- Distributing
- Asset Class
- Equity
- Asset Class Size
- Mid-Cap
- Asset Class Style
- Growth
- Assets Under Management
- $16M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
BOUT Performance Chart
Innovator IBD Breakout Opportunities ETF (BOUT) is up 34.4% since the beginning of the year. BOUT is currently trading at $49 per share. Investors who bought $1,000 worth of BOUT shares 5 years ago would now be looking at an investment worth $1,533.
Loading charts...
Returns By Period
Innovator IBD Breakout Opportunities ETF (BOUT) has returned 34.44% so far this year and 38.59% over the past 12 months.
Innovator IBD Breakout Opportunities ETF
- 1D
- 1.34%
- 1M
- 5.57%
- YTD
- 34.44%
- 6M
- 31.27%
- 1Y
- 38.59%
- 3Y*
- 17.65%
- 5Y*
- 8.92%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.15%
- 1Y
- 24.03%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
BOUT Monthly Returns History
Based on dividend-adjusted daily data since Sep 13, 2018, BOUT's average daily return is +0.05%, while the average monthly return is +0.94%. At this rate, an investment would double in approximately 6.2 years.
Historically, 57% of months were positive and 43% were negative. The best month was Nov 2020 with a return of +19.5%, while the worst month was Oct 2018 at -17.3%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 4 months.
On a daily basis, BOUT closed higher 55% of trading days. The best single day was Mar 24, 2020 with a return of +7.0%, while the worst single day was Mar 16, 2020 at -9.4%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 6.41% | 5.71% | -3.79% | 15.31% | 2.74% | 4.86% | 34.44% | ||||||
| 2025 | 3.77% | -5.91% | -4.91% | -7.35% | 4.37% | 4.26% | 2.35% | 0.96% | 3.14% | -3.05% | -0.86% | -2.75% | -6.77% |
| 2024 | -0.23% | 7.26% | 2.63% | -7.35% | 4.44% | -0.99% | 3.77% | 1.47% | -0.16% | 0.06% | 11.60% | -3.81% | 18.82% |
| 2023 | 4.08% | -1.59% | 2.83% | -1.11% | -4.85% | 10.04% | 3.40% | -5.76% | -3.42% | -4.37% | 6.50% | 8.39% | 13.27% |
| 2022 | -10.75% | 5.88% | 3.57% | -8.13% | -1.10% | -12.46% | 5.65% | -2.83% | -9.38% | 10.28% | 1.34% | -4.37% | -22.60% |
| 2021 | 4.27% | 3.13% | -2.53% | 4.17% | -4.90% | 1.48% | 2.52% | 4.09% | -3.51% | 6.67% | -0.60% | 6.65% | 22.69% |
Benchmark Metrics
Innovator IBD Breakout Opportunities ETF has an annualized alpha of -0.77%, beta of 0.88, and R2 of 0.57 versus S&P 500 Index. Calculated based on daily prices since September 13, 2018.
- This ETF participated in 96.67% of S&P 500 Index downside but only 84.33% of its upside - more exposed to losses than it benefited from rallies.
- With beta of 0.88 and R2 of 0.57, this ETF moves broadly in line with S&P 500 Index - much of its variation is explained by market exposure rather than independent behavior.
- Alpha
- -0.77%
- Beta
- 0.88
- R²
- 0.57
- Upside Capture
- 84.33%
- Downside Capture
- 96.67%
Expense Ratio
BOUT has an expense ratio of 0.80%, placing it in the medium range.
Return for Risk
Risk / Return Rank
BOUT ranks 56 for risk / return — on par with similar ETFs. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Innovator IBD Breakout Opportunities ETF (BOUT) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BOUT | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.25 | ||
| Sortino ratioReturn per unit of downside risk | -0.38 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.37 | -0.06 |
| Calmar ratioReturn relative to maximum drawdown | 3.30 | 2.78 | +0.51 |
| Martin ratioReturn relative to average drawdown | 9.76 | 12.44 | -2.68 |
Dividends
Dividend History
Innovator IBD Breakout Opportunities ETF provided a 0.26% dividend yield over the last twelve months, with an annual payout of $0.12 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.12 | $0.12 | $0.23 | $0.44 | $0.40 | $0.00 | $0.00 | $0.00 | $0.04 |
Dividend yield | 0.26% | 0.34% | 0.60% | 1.32% | 1.35% | 0.00% | 0.00% | 0.00% | 0.22% |
Monthly Dividends
The table displays the monthly dividend distributions for Innovator IBD Breakout Opportunities ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.12 | $0.12 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.23 | $0.23 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.44 | $0.44 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.40 | $0.40 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Innovator IBD Breakout Opportunities ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Innovator IBD Breakout Opportunities ETF was 36.98%, occurring on Mar 20, 2020. Recovery took 142 trading sessions.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
COVID crash2020 | -36.98%Mar 2020 | 1y 6mo | 6mo 26d | 2y 1moSep 2018 - Oct 2020 |
Bear market2022 | -28.28%Sep 2022 | 9mo 1d | 2y 1mo | 2y 10moDec 2021 - Nov 2024 |
2025 selloff2025 | -25.31%Apr 2025 | 4mo | 1y 1d | 1y 4moDec 2024 - Apr 2026 |
2021 correction2021 | -14.69%May 2021 | 3mo 7d | 5mo 10d | 8mo 17dFeb 2021 - Nov 2021 |
2021 pullback2021 | -8.18%Jan 2021 | 7d | 9d | 16dJan 2021 - Feb 2021 |
Drawdown Indicators
| BOUT | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -36.98% | -56.78% | +19.80% |
Max Drawdown (1Y)Largest decline over 1 year | -11.76% | -9.10% | -2.66% |
Max Drawdown (3Y)Largest decline over 3 years | -25.31% | -18.90% | -6.41% |
Max Drawdown (5Y)Largest decline over 5 years | -28.28% | -25.43% | -2.85% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | 0.00% | -1.80% | +1.80% |
Average DrawdownAverage peak-to-trough decline | -12.30% | -10.71% | -1.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.97% | 2.03% | +1.94% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with BOUT
Add Innovator IBD Breakout Opportunities ETF to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with BOUT